Must-Reads Of The Week From Brianna Labuskes
KHN鈥檚 newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don鈥檛 have to.
The independent source for health policy research, polling, and news.
521 - 540 of 698 Results
KHN鈥檚 newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don鈥檛 have to.
In this episode of KHN鈥檚 鈥淲hat the Health?鈥 Sarah Jane Tribble of Kaiser Health News, Joanne Kenen of Politico, Margot Sanger-Katz of The New York Times and Paige Winfield Cunningham of The Washington Post examine how even after Republicans failed to repeal and replace the Affordable Care Act, the health care debate continues to roil politics. They discuss how Republicans in Congress have shifted their ACA messaging and how the Democrats are looking to Medicare expansion. They also discuss state efforts to expand Medicaid and drug pricing. And they spend a moment talking about Congress鈥 push to do something about the opioid crisis.
Surgeon General Jerome Adams urged more people to carry the drug naloxone, a lifesaving treatment for opioid overdoses. But this policy is tricky to implement.
Roughly half of patients don't take their high blood pressure medicine as they should, even though heart disease is the leading cause of death in America. Now, a drug test can flag whether a patient is taking the prescribed medication and is meant to spark a more truthful conversation between patient and doctor.
The decision in Maryland鈥檚 case could slow momentum for other states that are attempting to take action to curb high drug costs.
KHN's newsletter editor, Brianna Labuskes, wades through hundreds of health articles from the week so you don't have to.
An abortion drug invented decades ago is being used to treat Cushing鈥檚 syndrome 鈥 and it鈥檚 bringing in tens of millions of dollars a year.
Kaiser Health News reporter Sarah Jane Tribble sat down with Food and Drug Administration Commissioner Scott Gottlieb on C-SPAN鈥檚 "Newsmakers" program. The conversation ranged from how the nation should combat the opioid epidemic to reining in drug prices.
In this episode of KHN鈥檚 鈥淲hat the Health?鈥 Julie Rovner of Kaiser Health News, Sarah Kliff of Vox.com, Anna Edney of Bloomberg News and Alice Ollstein of Talking Points Memo discuss President Donald Trump鈥檚 firing of David Shulkin, the secretary of Veterans Affairs, and Shulkin鈥檚 claim that he was forced out by those who want to privatize VA health care.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
In this episode of KHN鈥檚 鈥淲hat the Health?鈥 Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Anna Edney of Bloomberg News and Margot Sanger-Katz of The New York Times discuss the apparent demise of bipartisan legislation aimed at shoring up parts of the Affordable Care Act. They also discuss aggressive new efforts by the Food and Drug Administration to regulate tobacco products. Plus, for extra credit, the panelists offer their favorite health policy stories of the week.
Almost three-quarters of Americans think the pharmaceutical industry has too much power in the nation鈥檚 capital, according to the Kaiser Family Foundation.
How a prescription wiped out one woman鈥檚 health reimbursement account, raising questions about prescription drug price tags and about how health care professionals deal (or don鈥檛) with medical costs.
Last month鈥檚 budget deal means Medicare beneficiaries are eligible for physical and occupational therapy indefinitely. Plus, prescription drug costs will fall for more seniors.
Researchers at the University of Southern California analyzed millions of prescriptions and concluded that close to a quarter paid copays that exceeded the cost of the drugs.
KHN correspondent Shefali Luthra answered a wide variety of questions about health care in a Reddit 鈥淎sk Me Anything鈥 chat.
In this episode of KHN鈥檚 鈥淲hat the Health?鈥 Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and new podcast panelist Anna Edney of Bloomberg News discuss this week鈥檚 spate of speeches by the leaders of the Department of Health and Human Services. They also discuss the slow progress on health legislation on Capitol Hill intended to fund the government and stabilize the individual insurance market. Plus, for extra credit, the panelists offer their favorite health policy stories of the week.
The market is flooded with 28 different medications for just 20,000 patients with the hereditary bleeding disorder. Yet intense competition hasn鈥檛 worked to bring costs down. Sales amount to $4.6 billion annually in the U.S.
Saving the lives of people with the bleeding disorder can require high doses of expensive blood-clotting factor. Taxpayers foot much of the bill as manufacturers profit enormously.
漏 2026 KFF